Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Evans

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Current Pharmaceutical Design|June 12, 2012
The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response predictionSidney H Kennedy, Jonathan Downar, Kenneth R Evans, et al.
Journal of Clinical Psychopharmacology|January 18, 2006
Rating the raters: assessing the quality of Hamilton rating scale for depression clinical interviews in two industry-sponsored clinical drug trialsNina Engelhardt, Alan D Feiger, Kenneth O Cogger, et al.
Journal of Sex & Marital Therapy|January 19, 2006
Reliability and validity of the Sexual Interest and Desire Inventory-Female (SIDI-F), a scale designed to measure severity of female hypoactive sexual desire disorderAnita H Clayton, R Taylor Segraves, Sandra Leiblum, et al.
The American Journal of Psychiatry|December 7, 2005
Why the Hamilton Depression Rating Scale enduresPer Bech, Nina Engelhardt, Kenneth R Evans, et al.
Journal of Psychiatric Research|December 24, 2018
Plasma microRNA expression levels and their targeted pathways in patients with major depressive disorder who are responsive to duloxetine treatmentHelena Kyunghee Kim, Kathrin Tyryshkin, Nika Elmi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2011
An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriersAnthony L Vaccarino, Karen Anderson, Beth Borowsky, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 24, 2015
miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell CarcinomaHeba W Z Khella, Henriett Butz, Qiang Ding, et al.
Molecular & Cellular Proteomics : MCP|February 24, 2011
Identification of differentially regulated secretome components during skeletal myogenesisC Y X'avia Chan, Olena Masui, Olga Krakovska, et al.
Clinical Chemistry|August 21, 2013
MicroRNA signature helps distinguish early from late biochemical failure in prostate cancerZsuzsanna Lichner, Annika Fendler, Carol Saleh, et al.
Innovations in Clinical Neuroscience|December 16, 2016
The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive DisorderAnthony L Vaccarino, Kenneth R Evans, Amir H Kalali, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Design|June 12, 2012
The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response predictionSidney H Kennedy, Jonathan Downar, Kenneth R Evans, et al.
Journal of Clinical Psychopharmacology|January 18, 2006
Rating the raters: assessing the quality of Hamilton rating scale for depression clinical interviews in two industry-sponsored clinical drug trialsNina Engelhardt, Alan D Feiger, Kenneth O Cogger, et al.
Journal of Sex & Marital Therapy|January 19, 2006
Reliability and validity of the Sexual Interest and Desire Inventory-Female (SIDI-F), a scale designed to measure severity of female hypoactive sexual desire disorderAnita H Clayton, R Taylor Segraves, Sandra Leiblum, et al.
The American Journal of Psychiatry|December 7, 2005
Why the Hamilton Depression Rating Scale enduresPer Bech, Nina Engelhardt, Kenneth R Evans, et al.
Journal of Psychiatric Research|December 24, 2018
Plasma microRNA expression levels and their targeted pathways in patients with major depressive disorder who are responsive to duloxetine treatmentHelena Kyunghee Kim, Kathrin Tyryshkin, Nika Elmi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2011
An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriersAnthony L Vaccarino, Karen Anderson, Beth Borowsky, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 24, 2015
miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell CarcinomaHeba W Z Khella, Henriett Butz, Qiang Ding, et al.
Molecular & Cellular Proteomics : MCP|February 24, 2011
Identification of differentially regulated secretome components during skeletal myogenesisC Y X'avia Chan, Olena Masui, Olga Krakovska, et al.
Clinical Chemistry|August 21, 2013
MicroRNA signature helps distinguish early from late biochemical failure in prostate cancerZsuzsanna Lichner, Annika Fendler, Carol Saleh, et al.
Innovations in Clinical Neuroscience|December 16, 2016
The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive DisorderAnthony L Vaccarino, Kenneth R Evans, Amir H Kalali, et al.
Pageof 4